List of works - Marylou Cardenas Turanzas

Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study

scientific article

Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukemia: results with four tyrosine kinase inhibitor modalities

scientific article published on 25 April 2013

Place of death in the population dying from diseases indicative of palliative care need: a cross-national population-level study in 14 countries

scientific article published on 22 July 2015

International variation in place of death of older people who died from dementia in 14 European and non-European countries

scientific article published on 18 December 2014

A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemia

scientific article

Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy

scientific article published on 7 March 2014

The clinical effectiveness of optical spectroscopy for the in vivo diagnosis of cervical intraepithelial neoplasia: where are we?

scientific article published on October 2007

Natural history of cervical intraepithelial neoplasia: a meta-analysis

scientific article published in July 2005

Impact of comorbidities by ACE‐27 in the revised‐IPSS for patients with myelodysplastic syndromes

scientific article published on February 21, 2014

Differences in place of death between lung cancer and COPD patients: a 14-country study using death certificate data

scientific article

Patient-driven discontinuation of tyrosine kinase inhibitors: single institution experience

scientific article

Improving outcomes for patients with acute myeloid leukemia in first relapse: a single center experience

scientific article

Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3-ITD

scientific article

Clinical significance of microcytosis in patients with primary myelofibrosis

scientific article

Inclusion of palliative care in health care policy for older people: A directed documentary analysis in 13 of the most rapidly ageing countries worldwide

scientific article published on 09 December 2020

Expectations of serious adverse events at the end of life of patients with acute myeloid leukemia who receive salvage therapy

scientific article

List of works by Marylou Cardenas Turanzas

Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study

Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukemia: results with four tyrosine kinase inhibitor modalities

Place of death in the population dying from diseases indicative of palliative care need: a cross-national population-level study in 14 countries

International variation in place of death of older people who died from dementia in 14 European and non-European countries

A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemia

Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy

The clinical effectiveness of optical spectroscopy for the in vivo diagnosis of cervical intraepithelial neoplasia: where are we?

Natural history of cervical intraepithelial neoplasia: a meta-analysis

Impact of comorbidities by ACE‐27 in the revised‐IPSS for patients with myelodysplastic syndromes

Differences in place of death between lung cancer and COPD patients: a 14-country study using death certificate data

Patient-driven discontinuation of tyrosine kinase inhibitors: single institution experience

Improving outcomes for patients with acute myeloid leukemia in first relapse: a single center experience

Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3-ITD

Clinical significance of microcytosis in patients with primary myelofibrosis

Inclusion of palliative care in health care policy for older people: A directed documentary analysis in 13 of the most rapidly ageing countries worldwide

Expectations of serious adverse events at the end of life of patients with acute myeloid leukemia who receive salvage therapy